The 21st International AIDS Conference (AIDS 2016) programme will feature the latest evidence and best practices in the HIV response to optimize research to improve the quality of programmes being delivered in real-world settings. The programme will present strategies that make effective and efficient use of human, financial and other key resources to close the gaps between policy and ultimately implementation.

Scientific Programme Highlights

Programme highlights with some of the latest scientific findings include:
  • The latest findings on HIV self-testing from healthcare workers providing integrated HIV and sexual and reproductive health services
  • Key learnings on the uptake of Prevention of Mother-to-Child Transmission (PMTCT) and maternal behavioural outcomes
  • Leading approaches to cost-effectiveness of on-demand PrEP for men who have sex with men
  • A promising new strategy to integrate tuberculosis and HIV services for co-infected patients, which allows for increased adherence to antiretroviral treatment
  • Compelling insights on tracking investment from research to rollout of new prevention technologies
  • New SEARCH study results on streamlined HIV care in resource-limited settings
  • Progress on removing system barriers to implement integrated family planning (FP) and HIV services

Conference Session Highlights

Highlights from some of the sessions, meetings, and speakers include:
  • Pre-conference UN 90-90-90 Workshop: A Vehicle for Knowledge Translation of Treatment as Prevention, discussing research, programme and policy, implementation and progress-to-date related to the 90-90-90 targets
  • Implementation-focused AIDS 2016 plenary, including "Implications of Gender on the Response" by Elizabeth Anne Bukusi, Kenyan Medical Research Institute, and Maurine Murenga, International Community of Women Living with HIV; "Universal Access: Systems for Health in the Immediate Treatment Era" by Alex Coutinho, Accordia Global Health Foundation; “Prevention Equity: Uptake and Innovations in Testing, Prevention, Reducing Incidence” by the principal investigator of the Test and Treat study Nittaya Phanuphak, Thai Red Cross AIDS Research Centre; "TB and Co-infections, Co-morbidities: The Long Game" by Anton Pozniak, Chelsea and Westminster Hospital; "Towards a New Treatment Era?: Translating Results from START and TEMPRANO to Clinical Practice" by Serge Paul Eholié, Treichville University Teaching Hospital; "Essential Medicines, IP and Access" by Malebona Precious Matsoso, National Department of Health South Africa; and closing plenary "What's New, What's Next, What's Ahead?" by Carlos del Rio, Emory Center for AIDS Research
Copyright © 2016 International AIDS Society, All rights reserved.